An Aesthetic Revolution for LASTING Beauty

THE PAST AND THE FUTURE THE PAST
Aesthetic corrections of the face have traditionally been performed with injectable, re-absorbable products. Although often satisfactory, their effect is only short-term and the treatment must be repeated frequently at short intervals.

THE FUTURE
AQUAMID® is a non re-absorbable, long-lasting product for facial correction. It does not become hard once injected and does not migrate from the point of injection. Scientific research has shown that the gel will stay in its place unchanged for at least 10 years and there is no reason to expect any changes after this period. The cosmetic result is satisfying for both you and the doctor and the procedure does not have to be repeated once the desired result is achieved. In 80% of cases this is after one or two procedures. Progressive ageing of the skin does continue and if required, AQUAMID® extra can be injected as necessary.

FACIAL CORRECTIONS WITH AQUAMID®

• Wrinkle treatment, for example glabellar frowns, nosolabial folds, depressed corners of the mouth
• Lip augmentation
• Correction of acne scars
• Augmentation of chin, forehead or cheekbones
• Augmentation of depressed cheeks
• Other facial corrections

EASY AND SAFE

EASY
AQUAMID® is injected under the skin as a soft filling with a fine needle.Together with the doctor you can decide, in front of
the mirror, what the final cosmetic result should be.It is performed in the doctor's rooms with hardly any discomfort and no down time. After the injection you can go home or back to work immediately.

SAFE
AQUAMID® is a revolutionary product on the world market and has been thoroughly tested over 10 years on more than 100,000 patients. Clinical trials in Europe have proved that any side effects are few and harmless. At first, the treated area may be a little swollen., but this usually subsides spontaneously after one or two days.
AQUAMID® is developed and manufactured in Denmark to the highest international standards of quality and safety control.